פאנדי 50 יח'מל ( פקטור 8 )

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

FACTOR VIII (HUMAN)

Disponible depuis:

MEDICI MEDICAL LTD, ISRAEL

Code ATC:

B02BD02

forme pharmaceutique:

אבקה להכנת תמיסה לזריקה

Composition:

FACTOR VIII (HUMAN) 500 IU

Mode d'administration:

תוך-ורידי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

INSTITUTO GRIFOLS S.A.,SPAIN,BARCELONA

Groupe thérapeutique:

COAGULATION FACTOR VIII

Domaine thérapeutique:

COAGULATION FACTOR VIII

indications thérapeutiques:

Is indicated for the prevention and control of bleeding in patients with moderate or severe factor VIII deficiency due to classical hemophilia A . Fanhdi is not effective in controlling the bleeding of patients with Von Willebrond's disease.

Date de l'autorisation:

2020-12-31